PCMC
EDIT icon

Planning Capital Management Corporation’s Editas Medicine EDIT Stock Holding History

Planning Capital Management Corporation’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$24 Hold
7
– – ﹤0.01% 763
2024
Q2 		$33 Buy
+7
New +$39 ﹤0.01% 695

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Planning Capital Management Corporation's EDIT Position: Q3 2024 in Review

Planning Capital Management Corporation held its Editas Medicine (EDIT) position steady in Q3 2024 at 7 shares worth $24. The position accounts for ﹤0.01% of the portfolio, ranked #763.

Planning Capital Management Corporation first reported a position in EDIT in Q2 2024 and has held it in 2 quarters since. The position peaked at $33 in Q2 2024. 230 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.

  • Planning Capital Management Corporation held 7 shares of Editas Medicine worth $24 as of Q3 2024.
  • Planning Capital Management Corporation left its Editas Medicine share count unchanged in Q3 2024.
  • Editas Medicine made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #763 holding.
  • Planning Capital Management Corporation first reported a position in Editas Medicine in Q2 2024 and has held it in 2 quarters since.
  • Planning Capital Management Corporation's Editas Medicine position peaked at $33 in Q2 2024.
  • 230 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.